Indaptus Therapeutics, Inc.
INDP • NASDAQ
Indaptus Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David Elliot Lazar, with a market cap of $4.0M.
CEODavid Elliot Lazar
Next Earnings
Upcoming earnings announcement for Indaptus Therapeutics, Inc.
Date
Wednesday, May 13, 2026 (in a month)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$1.87
Earnings History
Past 12 earnings reports for Indaptus Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 17, 2026 | Q4 2025 | -$3.10Est: -$1.87 | -65.8% | - | — | — |
| Nov 12, 2025 | Q3 2025 | -$2.98Est: -$4.17 | +28.5% | - | — |  10-Q |
| Aug 13, 2025 | Q2 2025 | -$9.09 | — | - | — | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.32Est: -$0.41 | +22.0% | - | — | 10-Q |
| Mar 13, 2025 | Q4 2024 | -$0.38Est: -$0.41 | +7.3% | - | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.32Est: -$0.42 | +23.8% | - | — | 10-Q |
| Aug 12, 2024 | Q2 2024 | -$0.47Est: -$0.54 | +13.0% | - | — | 10-Q |
| May 8, 2024 | Q1 2024 | -$0.45Est: -$0.44 | -2.3% | - | — | 10-Q |
| Mar 13, 2024 | Q4 2023 | -$0.46Est: -$0.54 | +14.8% | - | — | 10-K |
| Nov 6, 2023 | Q3 2023 | -$0.47Est: -$0.55 | +14.5% | - | — | — |
| Aug 14, 2023 | Q2 2023 | -$0.39Est: -$0.58 | +32.8% | - | — | 10-Q |
| May 11, 2023 | Q1 2023 | -$0.51Est: -$0.59 | +13.6% | - | — | 10-Q |